Literature DB >> 16175017

A comparison of the Addenbrooke's Cognitive Examination (ACE), conventional neuropsychological assessment, and simple MRI-based medial temporal lobe evaluation in the early diagnosis of Alzheimer's disease.

Clare J Galton1, Sharon Erzinçlioglu, Barbara J Sahakian, Nagui Antoun, John R Hodges.   

Abstract

OBJECTIVE: To examine the contribution of the Addenbrooke's Cognitive Examination (ACE), neuropsychological assessment, and a magnetic resonance imaging (MRI)-based temporal lobe rating scale to the prediction of which patients with questionable dementia will progress to Alzheimer's disease (AD).
METHODS: Fifty subjects (19 early AD, 31 questionable dementia [QD]) underwent the ACE, a neuropsychological evaluation, and a volumetric MRI. The degree of atrophy of hippocampal, parahippocampal, and other temporal lobe structures was assessed using a validated visual rating scale. Subjects were followed 8 monthly for an average of 19.1 months.
RESULTS: Of the 31 QD subjects, 11 converted to AD within 24 months of follow-up (another 2 developed dementia with Lewy bodies) and 18 were nonconverters. Converters were impaired relative to nonconverters at baseline on measures of episodic and semantic memory (category fluency and naming) and the ACE. Converters also had a greater degree of hippocampal and parahippocampal atrophy. Discriminant analysis demonstrated that the best single test for distinguishing converters was the ACE. In combination, the hippocampal rating and category fluency were also contributory.
CONCLUSIONS: Progression to AD in patients with QD is best predicted by neuropsychological measures, particularly those that assess episodic and semantic memory, although simple rating methods based on MRI may have an adjunctive role.

Entities:  

Mesh:

Year:  2005        PMID: 16175017     DOI: 10.1097/01.wnn.0000182831.47073.e9

Source DB:  PubMed          Journal:  Cogn Behav Neurol        ISSN: 1543-3633            Impact factor:   1.600


  11 in total

Review 1.  Alliance for aging research AD biomarkers work group: structural MRI.

Authors:  Clifford R Jack
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

2.  The Philadelphia Brief Assessment of Cognition (PBAC): a validated screening measure for dementia.

Authors:  David J Libon; Katya Rascovsky; Rachel G Gross; Matthew T White; Sharon X Xie; Michael Dreyfuss; Ashley Boller; Lauren Massimo; Peachie Moore; Jessica Kitain; H Branch Coslett; Anjan Chatterjee; Murray Grossman
Journal:  Clin Neuropsychol       Date:  2011-11-15       Impact factor: 3.535

3.  Sparse canonical correlation analysis relates network-level atrophy to multivariate cognitive measures in a neurodegenerative population.

Authors:  Brian B Avants; David J Libon; Katya Rascovsky; Ashley Boller; Corey T McMillan; Lauren Massimo; H Branch Coslett; Anjan Chatterjee; Rachel G Gross; Murray Grossman
Journal:  Neuroimage       Date:  2013-10-02       Impact factor: 6.556

4.  Outcome in subgroups of mild cognitive impairment (MCI) is highly predictable using a simple algorithm.

Authors:  Joanna Mitchell; Robert Arnold; Kate Dawson; Peter J Nestor; John R Hodges
Journal:  J Neurol       Date:  2009-05-12       Impact factor: 4.849

5.  Neuropsychological Measures that Predict Progression from Mild Cognitive Impairment to Alzheimer's type dementia in Older Adults: a Systematic Review and Meta-Analysis.

Authors:  Sylvie Belleville; Céline Fouquet; Carol Hudon; Hervé Tchala Vignon Zomahoun; Jordie Croteau
Journal:  Neuropsychol Rev       Date:  2017-10-10       Impact factor: 7.444

6.  Evaluating the reliability of neurocognitive biomarkers of neurodegenerative diseases across countries: A machine learning approach.

Authors:  M Belen Bachli; Lucas Sedeño; Jeremi K Ochab; Olivier Piguet; Fiona Kumfor; Pablo Reyes; Teresa Torralva; María Roca; Juan Felipe Cardona; Cecilia Gonzalez Campo; Eduar Herrera; Andrea Slachevsky; Diana Matallana; Facundo Manes; Adolfo M García; Agustín Ibáñez; Dante R Chialvo
Journal:  Neuroimage       Date:  2019-12-10       Impact factor: 6.556

7.  [The current diagnostic approach for chronic progressive dementia].

Authors:  C Bartels; C W Wallesch
Journal:  Nervenarzt       Date:  2007-05       Impact factor: 1.297

8.  Self administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study.

Authors:  Jeremy Brown; George Pengas; Kate Dawson; Lucy A Brown; Philip Clatworthy
Journal:  BMJ       Date:  2009-06-09

9.  Addenbrooke's Cognitive Examination-Revised is accurate for detecting dementia in Parkinson's disease patients with low educational level.

Authors:  Maria Sheila Guimarães Rocha; Elida Maria Bassetti; Maira Okada Oliveira; Roberta Gomes Borges Kuark; Nathercia Marinho Estevam; Sonia Maria Dozzi Brucki
Journal:  Dement Neuropsychol       Date:  2014 Jan-Mar

10.  Efficacy of herbal combination of sedge, saffron, and Astragalus honey on major neurocognitive disorder.

Authors:  Shahla Akouchekian; Victoria Omranifard; Mohamad Reza Maracy; Ainour Pedram; Asiyeh Almasi Zefreh
Journal:  J Res Med Sci       Date:  2018-06-06       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.